Physician profile
Scott Naftulin
NPI 1861485369
$6,406.10
in general payments reported to CMS, 2019-2025
15 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,257 · 2020: $35.70 · 2021: $127 · 2022: $206 · 2023: $3,882 · 2024: $764 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $3,769 · Travel and Lodging: $539 · Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $3,769.40 |
| Travel and Lodging | $539.24 |
| Food and Beverage | $471.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Rehabilitative Sciences, INC | $3,808.10 | 2023 | Rs 4i Plus Sequential Stimulator, Rs-Lbg/Fbg |
| Vertiflex, INC. | $989.94 | 2019 | |
| Curonix LLC | $556.88 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $249.38 | 2019-2022 | |
| Boston Scientific Corporation | $244.26 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16, Infinion 16 |
| Spr Therapeutics, INC | $133.33 | 2019 | |
| Paragon 28, INC. | $119.52 | 2024 | Precision Mis Bunion |
| Si-Bone, INC. | $104.87 | 2019 | |
| Nevro Corp. | $59.02 | 2020-2024 | Senza |
| Electronic Waveform Lab, INC. | $34.09 | 2025 | |
| Saluda Medical Americas, INC. | $27.28 | 2024 | Evoke |
| Biotronik Nro, INC. | $25.52 | 2025 | Prospera |
| Mml US, INC. | $22.95 | 2023 | Reactiv8 |
| Medtronic, INC. | $17.09 | 2023 | Intellis Adaptivestim |
| Abbvie INC. | $13.87 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Naftulin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.